A detailed history of Qtron Investments LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Qtron Investments LLC holds 5,019 shares of RDY stock, worth $70,767. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,019
Previous 5,019 -0.0%
Holding current value
$70,767
Previous $382,000 4.19%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$68.26 - $76.19 $659,528 - $736,147
-9,662 Reduced 65.81%
5,019 $382,000
Q4 2023

Feb 12, 2024

BUY
$64.27 - $69.9 $237,156 - $257,931
3,690 Added 33.57%
14,681 $1.02 Million
Q3 2023

Nov 13, 2023

SELL
$61.9 - $72.77 $1.11 Million - $1.31 Million
-17,980 Reduced 62.06%
10,991 $734,000
Q2 2023

Aug 10, 2023

BUY
$53.34 - $63.11 $235,229 - $278,315
4,410 Added 17.96%
28,971 $1.83 Million
Q1 2023

May 11, 2023

BUY
$51.63 - $56.93 $677,385 - $746,921
13,120 Added 114.68%
24,561 $1.4 Million
Q4 2022

Feb 13, 2023

BUY
$51.15 - $57.45 $585,207 - $657,285
11,441 New
11,441 $592,000
Q1 2021

May 13, 2021

SELL
$57.98 - $73.08 $1.24 Million - $1.57 Million
-21,424 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$62.61 - $71.29 $224,769 - $255,931
-3,590 Reduced 14.35%
21,424 $1.53 Million
Q3 2020

Nov 12, 2020

SELL
$51.39 - $72.41 $764,169 - $1.08 Million
-14,870 Reduced 37.28%
25,014 $1.74 Million
Q2 2020

Aug 13, 2020

BUY
$39.55 - $54.65 $356,701 - $492,888
9,019 Added 29.22%
39,884 $2.11 Million
Q2 2019

Aug 13, 2019

BUY
$36.05 - $42.76 $77,038 - $91,378
2,137 Added 7.44%
30,865 $1.16 Million
Q1 2019

May 13, 2019

BUY
$35.77 - $40.57 $748,594 - $849,048
20,928 Added 268.31%
28,728 $1.16 Million
Q4 2018

Feb 14, 2019

BUY
$31.89 - $38.44 $248,742 - $299,832
7,800 New
7,800 $294,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.34B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.